News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
181 Results
Type
Article (32)
Press Release (149)
Section
Business (55)
Deals (2)
Drug Development (36)
FDA (1)
Job Trends (4)
News (88)
Policy (8)
Tag
Academia (1)
Alliances (10)
Approvals (1)
Bankruptcy (1)
Best Places to Work (2)
Clinical research (35)
Data (5)
Diagnostics (1)
Earnings (32)
Events (34)
FDA (1)
GLP-1 (3)
Government (3)
Healthcare (4)
IPO (1)
Layoffs (2)
Legal (1)
MASH (10)
Mergers & acquisitions (2)
Metabolic disorders (10)
NASH (5)
NextGen: Class of 2025 (1)
Non-profit (4)
Northern California (2)
People (13)
Phase I (6)
Phase II (23)
Phase III (15)
Preclinical (3)
Real estate (1)
Regulatory (7)
United States (41)
Date
Last 7 days (2)
Last 30 days (6)
Last 365 days (34)
2025 (9)
2024 (29)
2023 (26)
2022 (32)
2021 (23)
2020 (9)
2019 (13)
2018 (8)
2017 (22)
2016 (2)
2015 (1)
2014 (3)
2013 (3)
2012 (1)
Location
Asia (13)
California (2)
Europe (147)
Japan (1)
New York (41)
Northern California (2)
181 Results for "inventiva".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Inventiva to Halve Its Workforce, Shift Focus to MASH Candidate
French biotech Inventiva’s layoffs and pipeline shift are expected to help keep the company operational into the second half of 2026.
February 11, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux
January 27, 2025
·
15 min read
Press Releases
Inventiva reports preliminary 2024 fiscal year financial results¹ and provides a business update
February 11, 2025
·
17 min read
Press Releases
Inventiva announces the publication in Biomedicine & Pharmacotherapy of the results from a preclinical study showing improvement of portal hypertension with lanifibranor treatment
February 27, 2025
·
13 min read
Press Releases
Inventiva and Hepalys Pharma, Inc. announce the initiation of the clinical development program of lanifibranor in Japan with the dosing of the first participant in Phase 1 trial
February 21, 2025
·
12 min read
Press Releases
Inventiva reports 2024 Third Quarter Financial Information¹
November 22, 2024
·
16 min read
Press Releases
Inventiva to present at the 43rd Annual J.P. Morgan Healthcare Conference
December 17, 2024
·
2 min read
Press Releases
Inventiva announces the publication of the results from the investigator-initiated proof-of-concept clinical trial evaluating lanifibranor in patients with T2D and MASLD in the Journal of Hepatology
January 30, 2025
·
13 min read
Pharm Country
Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux
Inventiva announced the half-year report of its liquidity contract with Kepler Cheuvreux.
January 24, 2024
·
13 min read
Business
Inventiva reports 2024 First Quarter Financial Information¹ and provides a corporate update
Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”) today reported financial information for the first quarter of 2024, including its cash, cash equivalents and revenues, and provided a corporate update.
May 21, 2024
·
15 min read
1 of 19
Next
